European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice

BACKGROUND: Despite the benefits biosimilars offer in terms of cost savings and patient access, healthcare professionals and patients have been reluctant to use them. Next to insufficient understanding of and trust in biosimilars, healthcare professionals and patients have questions about switching...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbier, Liese, Simoens, Steven, Vulto, Arnold G., Huys, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669768/
https://www.ncbi.nlm.nih.gov/pubmed/33063267
http://dx.doi.org/10.1007/s40259-020-00440-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669768/
https://www.ncbi.nlm.nih.gov/pubmed/33063267
http://dx.doi.org/10.1007/s40259-020-00440-z

Ejemplares similares